149 related articles for article (PubMed ID: 2126953)
21. Gamma-interferon induced human keratinocyte HLA-DR synthesis: the role of dermal activated T lymphocytes.
Barker JN; Navsaria HA; Leigh IM; MacDonald DM
Br J Dermatol; 1988 Nov; 119(5):567-72. PubMed ID: 2462899
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-2 stimulates resting human T lymphocytes' response to allogeneic, gamma interferon-treated keratinocytes.
Morhenn VB; Nickoloff BJ
J Invest Dermatol; 1987 Nov; 89(5):464-8. PubMed ID: 3117903
[TBL] [Abstract][Full Text] [Related]
23. In situ localization of IFN-gamma-positive cells in psoriatic lesional epidermis.
Koga T; Duan H; Urabe K; Furue M
Eur J Dermatol; 2002; 12(1):20-3. PubMed ID: 11809590
[TBL] [Abstract][Full Text] [Related]
24. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Invest Dermatol; 1995 Jul; 105(1 Suppl):89S-94S. PubMed ID: 7616005
[TBL] [Abstract][Full Text] [Related]
25. Lymphocyte trafficking in psoriasis: a new perspective emphasizing the dermal dendrocyte with active dermal recruitment mediated via endothelial cells followed by intra-epidermal T-cell activation.
Nickoloff BJ; Griffiths CE
J Invest Dermatol; 1990 Nov; 95(5 Suppl):35S-37S. PubMed ID: 16788628
[TBL] [Abstract][Full Text] [Related]
26. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products.
Prinz JC; Gross B; Vollmer S; Trommler P; Strobel I; Meurer M; Plewig G
Eur J Immunol; 1994 Mar; 24(3):593-8. PubMed ID: 8125129
[TBL] [Abstract][Full Text] [Related]
27. Expression of interferon-gamma receptors in normal and psoriatic skin.
Scheynius A; Fransson J; Johansson C; Hammar H; Baker B; Fry L; Valdimarsson H
J Invest Dermatol; 1992 Feb; 98(2):255-8. PubMed ID: 1531061
[TBL] [Abstract][Full Text] [Related]
28. Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop.
Terui T; Ozawa M; Tagami H
Exp Dermatol; 2000 Feb; 9(1):1-10. PubMed ID: 10688368
[TBL] [Abstract][Full Text] [Related]
29. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells.
Baadsgaard O; Gupta AK; Taylor RS; Ellis CN; Voorhees JJ; Cooper KD
J Invest Dermatol; 1989 Feb; 92(2):190-5. PubMed ID: 2645367
[TBL] [Abstract][Full Text] [Related]
30. Anti-CD4 monoclonal antibody therapy in severe psoriasis.
Morel P; Revillard JP; Nicolas JF; Wijdenes J; Rizova H; Thivolet J
J Autoimmun; 1992 Aug; 5(4):465-77. PubMed ID: 1384529
[TBL] [Abstract][Full Text] [Related]
31. T cells involved in psoriasis vulgaris belong to the Th1 subset.
Schlaak JF; Buslau M; Jochum W; Hermann E; Girndt M; Gallati H; Meyer zum Büschenfelde KH; Fleischer B
J Invest Dermatol; 1994 Feb; 102(2):145-9. PubMed ID: 8106745
[TBL] [Abstract][Full Text] [Related]
32. The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skin.
Rizova H; Nicolas JF; Morel P; Kanitakis J; Demidem A; Revillard JP; Wijdenes J; Thivolet J; Schmitt D
J Dermatol Sci; 1994 Feb; 7(1):1-13. PubMed ID: 8193079
[TBL] [Abstract][Full Text] [Related]
33. HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions.
Terui T; Aiba S; Kato T; Tanaka T; Tagami H
Br J Dermatol; 1987 Jan; 116(1):87-93. PubMed ID: 2434124
[TBL] [Abstract][Full Text] [Related]
34. Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions.
Baker BS; Laman JD; Powles A; van der Fits L; Voerman JS; Melief MJ; Fry L
J Pathol; 2006 Jun; 209(2):174-81. PubMed ID: 16493599
[TBL] [Abstract][Full Text] [Related]
35. HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis.
Shen Z; Wang G; Fan JY; Li W; Liu YF
J Dermatol Sci; 2005 Apr; 38(1):25-39. PubMed ID: 15795121
[TBL] [Abstract][Full Text] [Related]
36. Immunologic mechanisms in psoriasis.
Gottlieb AB
J Am Acad Dermatol; 1988 Jun; 18(6):1376-80. PubMed ID: 3290292
[TBL] [Abstract][Full Text] [Related]
37. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol).
Fukuoka M; Ogino Y; Sato H; Ohta T; Komoriya K; Nishioka K; Katayama I
Br J Dermatol; 1998 Jan; 138(1):63-70. PubMed ID: 9536224
[TBL] [Abstract][Full Text] [Related]
38. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
39. Preferential binding of monocytes and Leu 2+ T lymphocytes to interferon-gamma treated cultured skin endothelial cells and keratinocytes.
Nickoloff BJ; Reusch MK; Bensch K; Karasek MA
Arch Dermatol Res; 1988; 280(4):235-45. PubMed ID: 2466443
[TBL] [Abstract][Full Text] [Related]
40. Influence of psoriatic peripheral blood CD4+ T and CD8+ T lymphocytes on C-myc, Bcl-xL and Ki67 gene expression in keratinocytes.
Li X; Fan X; Zhang K; Yin G; Liu Y
Eur J Dermatol; 2007; 17(5):392-6. PubMed ID: 17673382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
